Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Pyridazine compounds >  3-Bromo-6-chloroimidazo[1,2-b]pyridazine

3-Bromo-6-chloroimidazo[1,2-b]pyridazine

Basic information Safety Supplier Related

3-Bromo-6-chloroimidazo[1,2-b]pyridazine Basic information

Product Name:
3-Bromo-6-chloroimidazo[1,2-b]pyridazine
Synonyms:
  • 3-Bromo-6-chloroimidazo[1,2-b]pyridazine
  • IMidazo[1,2-b]pyridazine, 3-broMo-6-chloro-
  • 3-Bromo-6-chloroimidazo[1,2-b]pyridazine98%
  • 3-Bromo-6-chloroimidazo[1,2-β]pyridazine
  • 6-Chloro-3-broMoiMidazo[1,2-a]pyridazine
  • 3-Bromo-6-chloroimidazo[1,2-b]pyridazine ISO 9001:2015 REACH
  • -Bromo-6-chloroimidazo[1,2-b]pyridazine
CAS:
13526-66-4
MF:
C6H3BrClN3
MW:
232.47
Product Categories:
  • blocks
  • Bromides
  • Heterocycles
  • Imidazoles
Mol File:
13526-66-4.mol
More
Less

3-Bromo-6-chloroimidazo[1,2-b]pyridazine Chemical Properties

Melting point:
156 °C
Density 
2.03
storage temp. 
under inert gas (nitrogen or Argon) at 2-8°C
form 
Solid
pka
0.73±0.30(Predicted)
Appearance
White to light yellow Solid
More
Less

Safety Information

Safety Statements 
24/25
HS Code 
29339900
More
Less

3-Bromo-6-chloroimidazo[1,2-b]pyridazine Usage And Synthesis

Uses

3-Bromo-6-chloroimidazo[1,2-b]pyridazine is a reagent in the synthesis of imidazopyridazine series of inhibitors of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1).

Synthesis

6775-78-6

13526-66-4

General procedure for the synthesis of 3-bromo-6-chloroimidazo[1,2-b]pyridazine from 6-chloroimidazo[1,2-b]pyridazine: 478 mg (3.11 mmol) of 6-chloroimidazo[1,2-b]pyridazine was dissolved in 10 mL of chloroform under the protection of argon and cooled in an ice bath. Subsequently, 664 mg (3.73 mmol) of N-bromosuccinimide was slowly added. After addition, the reaction mixture was stirred at room temperature overnight. Upon completion of the reaction, the mixture was mixed with water and ethyl acetate, and the organic and aqueous phases were separated by the addition of saturated sodium bicarbonate solution. The aqueous phase was extracted three times with ethyl acetate. The organic phase was combined, washed with saturated sodium chloride solution and dried over anhydrous sodium sulfate. The solvent was removed by concentration under reduced pressure to afford the target product 3-bromo-6-chloroimidazo[1,2-b]pyridazine as an amorphous white solid, which could be used in subsequent reactions without further chromatographic purification.1H-NMR (CDCl3, molecular sieve dried): δ = 7.12 (d, 1H); 7.79 (s, 1H); 7.90 (d, 1H) ppm.

References

[1] Patent: US2009/93475, 2009, A1. Location in patent: Page/Page column 6
[2] Patent: WO2013/34570, 2013, A1. Location in patent: Page/Page column 74
[3] Patent: WO2013/41634, 2013, A1. Location in patent: Page/Page column 73; 78; 87
[4] Patent: WO2013/144189, 2013, A1. Location in patent: Page/Page column 56
[5] Patent: WO2013/149909, 2013, A1. Location in patent: Page/Page column 60-61

3-Bromo-6-chloroimidazo[1,2-b]pyridazineSupplier

J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
ChangShu Haitian Fine Chemicals Co.,Ltd
Tel
13913622609
Email
974295387@qq.com
Energy Chemical
Tel
021-021-58432009 400-005-6266
Email
sales8178@energy-chemical.com
Wuhan Chemwish Technology Co., Ltd
Tel
86-027-67849912
Email
sales@chemwish.com
JinYan Chemicals(ShangHai) Co.,Ltd.
Tel
13817811078
Email
sales@jingyan-chemical.com